For the latest DTRF news sign up for one of our newsletters to stay informed.
To Be Announced: Pediatric clinical trial for nirogacestat. Learn about adult clinical trial.
FDA Approves Fast Track Designation for NirogacestatIn anticipation of the drug’s phase III trial
Tegavivint Trial LaunchesIterion Therapeutics, formerly known as Beta Cat Pharmaceuticals, today announced that it has initiated a multi-center Phase I clinical study of Tegavivint
Abstract for Phase II Pazopanib TrialDT are a group of locally aggressive tumors of fibroblastic origin that can lead
ASCO Presentation for Phase II Pazopanib TrialPazopanib versus IV methotrexate/vinblastine in
adult patients
DTRF’s 2019 Grant AwardsGerlinde Wernig, MD, Assistant Professor of Pathology, Standford Univesity School
Int’l DTRF Desmoid Tumor Research WorkshopSave the date for the Sept 25, 2020 DTRF International Desmoid Tumor Research Workshop
Desmoid Tumour Foundation of CanadaThey donated $100,000 to DTRF research initiatives in 2019!
Click here for archive of UPDATES

Save the date for the 11th Annual Running for Answers 5K and Kids’ Fun Run on Sept. 27, 2020
